ESC 365 - Effect of aspirin discontinuation according to individualised patient bleeding and ischemic risks after PCI: a TWILIGHT trial sub-analysis.

ESC Professional Premium Access

Effect of aspirin discontinuation according to individualised patient bleeding and ischemic risks after PCI: a TWILIGHT trial sub-analysis.

Session: Optimising PCI: imaging, pharmacology and more

Topic: Complications

Speaker: Doctor G. Mendieta Badimon (Barcelona, ES)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Guiomar Mendieta Badimon

Hospital de la Santa Creu i Sant Pau, Barcelona (Spain)

3 followers

3 more presentations in this session

Heparin pre-treatment in patients with ST elevation myocardial infarction: a cohort study investigating the effects on coronary artery occlusion, mortality, and bleeding

Speaker: Mr O. Emilsson (Lund, SE)

Intravascular ultrasound-guided optimization for chronic total occlusion-percutaneous coronary intervention with multiple drug-eluting stents

Speaker: Doctor S. Seo (Seoul, KR)

Shockwave intravascular lithotripsy (IVL) for calcified coronary lesions; a real world multicentre European study with long term follow up

Speaker: Doctor W. Raja (Birmingham, GB)

Access the full session

Optimising PCI: imaging, pharmacology and more

Speakers: Doctor G. Mendieta Badimon, Mr O. Emilsson, Doctor S. Seo, Doctor W. Raja

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources